{"id":104508,"date":"2020-03-30T20:43:06","date_gmt":"2020-03-31T03:43:06","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/03\/fda-approves-roches-actemra-covid-19-trial"},"modified":"2020-03-30T20:43:06","modified_gmt":"2020-03-31T03:43:06","slug":"fda-approves-roches-actemra-covid-19-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/03\/fda-approves-roches-actemra-covid-19-trial","title":{"rendered":"FDA approves Roche\u2019s Actemra COVID-19 trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-approves-roches-actemra-covid-19-trial.jpg\"><\/a><\/p>\n<p>Actemra (tocilizumab) \u2013 an interleukin-6 inhibitor \u2013 has already been approved in China for the treatment of patients infected with the novel coronavirus disease, who have developed serious lung damage and also have elevated levels of IL-6 in the blood.<\/p>\n<p>It was first cleared by the FDA as a treatment for rheumatoid arthritis and has also subsequently been approved in juvenile idiopathic arthritis, giant cell arteritis and CRS associated with CAR-T cell therapies for cancer.<\/p>\n<hr>\n<p>Plans to initiate trial in early April.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Actemra (tocilizumab) \u2013 an interleukin-6 inhibitor \u2013 has already been approved in China for the treatment of patients infected with the novel coronavirus disease, who have developed serious lung damage and also have elevated levels of IL-6 in the blood. It was first cleared by the FDA as a treatment for rheumatoid arthritis and has [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-104508","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/104508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=104508"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/104508\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=104508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=104508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=104508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}